IRIS Accounts Production v25.2.0.378 09160959 director 1.9.24 31.8.25 31.8.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh091609592024-08-31091609592025-08-31091609592024-09-012025-08-31091609592023-08-31091609592023-09-012024-08-31091609592024-08-3109160959ns15:EnglandWales2024-09-012025-08-3109160959ns14:PoundSterling2024-09-012025-08-3109160959ns10:Director12024-09-012025-08-3109160959ns10:PrivateLimitedCompanyLtd2024-09-012025-08-3109160959ns10:SmallEntities2024-09-012025-08-3109160959ns10:AuditExempt-NoAccountantsReport2024-09-012025-08-3109160959ns10:SmallCompaniesRegimeForDirectorsReport2024-09-012025-08-3109160959ns10:SmallCompaniesRegimeForAccounts2024-09-012025-08-3109160959ns10:FullAccounts2024-09-012025-08-3109160959ns10:RegisteredOffice2024-09-012025-08-3109160959ns5:CurrentFinancialInstruments2025-08-3109160959ns5:CurrentFinancialInstruments2024-08-3109160959ns5:ShareCapital2025-08-3109160959ns5:ShareCapital2024-08-3109160959ns5:RetainedEarningsAccumulatedLosses2025-08-3109160959ns5:RetainedEarningsAccumulatedLosses2024-08-3109160959ns5:LongLeaseholdAssetsns5:LandBuildings2024-09-012025-08-3109160959ns5:PlantMachinery2024-09-012025-08-3109160959ns5:FurnitureFittings2024-09-012025-08-3109160959ns5:MotorVehicles2024-09-012025-08-3109160959ns5:ComputerEquipment2024-09-012025-08-3109160959ns5:LongLeaseholdAssetsns5:LandBuildings2024-08-3109160959ns5:PlantMachinery2024-08-3109160959ns5:FurnitureFittings2024-08-3109160959ns5:LongLeaseholdAssetsns5:LandBuildings2025-08-3109160959ns5:PlantMachinery2025-08-3109160959ns5:FurnitureFittings2025-08-3109160959ns5:LongLeaseholdAssetsns5:LandBuildings2024-08-3109160959ns5:PlantMachinery2024-08-3109160959ns5:FurnitureFittings2024-08-3109160959ns5:MotorVehicles2024-08-3109160959ns5:ComputerEquipment2024-08-3109160959ns5:MotorVehicles2025-08-3109160959ns5:ComputerEquipment2025-08-3109160959ns5:MotorVehicles2024-08-3109160959ns5:ComputerEquipment2024-08-3109160959ns5:WithinOneYearns5:CurrentFinancialInstruments2025-08-3109160959ns5:WithinOneYearns5:CurrentFinancialInstruments2024-08-3109160959ns5:WithinOneYear2025-08-3109160959ns5:WithinOneYear2024-08-3109160959ns5:BetweenOneFiveYears2025-08-3109160959ns5:BetweenOneFiveYears2024-08-3109160959ns5:AllPeriods2025-08-3109160959ns5:AllPeriods2024-08-31
REGISTERED NUMBER: 09160959 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 AUGUST 2025

FOR

SENSE MEDICAL LIMITED

SENSE MEDICAL LIMITED (REGISTERED NUMBER: 09160959)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 August 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SENSE MEDICAL LIMITED

COMPANY INFORMATION
for the year ended 31 August 2025







DIRECTOR: A Jahangir





REGISTERED OFFICE: 3 Mulberry Court
59c London Road
Bagshot
Surrey
GU19 5DT





REGISTERED NUMBER: 09160959 (England and Wales)





ACCOUNTANTS: Magma Audit LLP
Unit 2 Charnwood Edge Business Park
Syston Road, Leicester
LE7 4UZ
Magma Audit LLP is part
Of the Dains Group

SENSE MEDICAL LIMITED (REGISTERED NUMBER: 09160959)

BALANCE SHEET
31 August 2025

2025 2024
Notes £    £   
FIXED ASSETS
Tangible assets 4 842,678 130,778

CURRENT ASSETS
Stocks 243,323 1,192,294
Debtors 5 655,642 216,794
Cash at bank 1,351,635 2,707,279
2,250,600 4,116,367
CREDITORS
Amounts falling due within one year 6 (1,312,361 ) (2,536,773 )
NET CURRENT ASSETS 938,239 1,579,594
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,780,917

1,710,372

PROVISIONS FOR LIABILITIES (167,741 ) -
NET ASSETS 1,613,176 1,710,372

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 1,612,976 1,710,172
1,613,176 1,710,372

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 May 2026 and were signed by:





A Jahangir - Director


SENSE MEDICAL LIMITED (REGISTERED NUMBER: 09160959)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 August 2025


1. STATUTORY INFORMATION

Sense Medical Limited is a limited company, registered in England and Wales. Its registered office address is 3 Mulberry Court, 59C London Road, Bagshot, Surrey, GU19 5DT and the registered number is 09160959.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The presentational currency of the financial statements is the Pound Sterling (£) and amounts are rounded to the nearest £1.

Transactions in currencies other than pound sterling are recorded at the rates on exchange prevailing at the date of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting date. Gains and losses arising on translation are included in the profit and loss account for the period.

Turnover
Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Long leasehold land & buildings - not provided
Plant and machinery - 33% straight line
Fixtures and fittings - 25% straight line
Motor vehicles - 33% on reducing balance
Computer equipment - 33% straight line

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

Financial instruments
(i) Financial assets

Basic financial assets, including trade and other debtors, cash and bank balances are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest rate method.

(ii) Financial liabilities

Basic financial liabilities, including trade and other creditors are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.


SENSE MEDICAL LIMITED (REGISTERED NUMBER: 09160959)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 August 2025


2. ACCOUNTING POLICIES - continued
Taxation
The tax expense for the year comprises current and deferred tax.

Tax is recognised in profit or loss except that a change attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance Sheet date, except that:
- The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
- Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Both current and deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Operating leases
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Leases that do not transfer all the risks and rewards of ownership are classified as operating leases. Payments under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Cash and cash equivalents
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

4. TANGIBLE FIXED ASSETS
Long
leasehold Fixtures
land & Plant and and
buildings machinery fittings
£    £    £   
COST
At 1 September 2024 - 96,918 12,788
Additions 775,953 - -
Disposals - (6,226 ) -
At 31 August 2025 775,953 90,692 12,788
DEPRECIATION
At 1 September 2024 - 49,329 10,518
Charge for year - 29,650 2,270
Eliminated on disposal - (3,113 ) -
At 31 August 2025 - 75,866 12,788
NET BOOK VALUE
At 31 August 2025 775,953 14,826 -
At 31 August 2024 - 47,589 2,270

SENSE MEDICAL LIMITED (REGISTERED NUMBER: 09160959)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 August 2025


4. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 September 2024 178,231 27,015 314,952
Additions - - 775,953
Disposals - (4,855 ) (11,081 )
At 31 August 2025 178,231 22,160 1,079,824
DEPRECIATION
At 1 September 2024 110,443 13,884 184,174
Charge for year 22,594 5,637 60,151
Eliminated on disposal - (4,066 ) (7,179 )
At 31 August 2025 133,037 15,455 237,146
NET BOOK VALUE
At 31 August 2025 45,194 6,705 842,678
At 31 August 2024 67,788 13,131 130,778

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 635,204 189,488
Amounts owed by group undertakings - 3,809
Other debtors 20,438 23,497
655,642 216,794

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 699,917 1,518,571
Taxation and social security 279,750 478,655
Other creditors 332,694 539,547
1,312,361 2,536,773

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2024
£    £   
Within one year 49,500 -
Between one and five years 33,542 -
83,042 -